Which two hepatitis viruses are commonly found together as a co‑infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hepatitis B and D (HBV/HDV) Are Most Commonly Found Together

The two hepatitis viruses most commonly found together as a co-infection are Hepatitis B (HBV) and Hepatitis D (HDV). This pairing is unique because HDV is a satellite virus that cannot exist without HBV—it requires HBV's envelope proteins to replicate 1.

Why HBV and HDV Co-infection Matters

HDV is completely dependent on HBV for its lifecycle, making this co-infection biologically obligatory rather than coincidental 1. This relationship occurs in two distinct patterns:

Two Forms of HBV/HDV Co-infection

Simultaneous coinfection: When both viruses are acquired at the same time, this typically causes more severe acute hepatitis with higher mortality than HBV alone, but rarely progresses to chronic infection 1.

HDV superinfection: When HDV infects someone who already has chronic HBV, this almost always (>90%) results in chronic infection with both viruses and represents the more dangerous scenario 1.

Clinical Significance and Outcomes

Patients with chronic HBV/HDV co-infection face significantly worse outcomes than those with HBV alone:

  • Higher rates of cirrhosis development (4% annually) 2
  • Increased hepatic decompensation 1
  • Higher risk of hepatocellular carcinoma (HCC) - 2.8% annually 2
  • Greater liver-related mortality 1
  • More severe liver disease overall 1, 3

Geographic Distribution

HBV/HDV coinfection occurs most commonly in the Mediterranean region and parts of South America, though prevalence has declined with HBV vaccination programs 1. In the United States, an estimated 32,700-52,500 people have active HDV infection 4.

Other Notable Co-infections (But Less Common)

While HBV and HCV co-infection does occur (estimated at 10-15% of chronic HBV patients), this is less common than HBV/HDV and represents independent infections sharing similar transmission routes rather than a biological dependency 1. HBV/HCV co-infected patients also experience accelerated liver disease and higher HCC rates compared to monoinfection 1.

Screening Recommendations

All patients with chronic HBV should be tested for HDV, particularly those with:

  • History of injection drug use 1
  • Origin from endemic areas (Mediterranean, South America) 1
  • Unexplained hepatitis flares or rapid disease progression 5

Active HDV infection is confirmed by detectable HDV RNA, though testing is not well standardized 2, 5. Anti-HDV antibodies indicate exposure but not necessarily active replication 2.

Related Questions

How should a 2‑month‑old infant with viral hepatitis, markedly elevated transaminases, normal bilirubin, normal coagulation profile, normal albumin, normal glucose, normal abdominal ultrasound, neutropenia with reactive lymphocytosis, and who has been receiving ampicillin, cefotaxime, and acyclovir for four days be managed given persistent transaminase elevation and worsening neutropenia without any clinical symptoms?
Should acyclovir be given for suspected viral hepatitis?
How can I differentiate acute versus chronic hepatitis B and acute versus chronic hepatitis C?
Can hepatitis B virus, hepatitis C virus, and HIV remain infectious after being stored in a normal household refrigerator (≈4 °C) for four weeks?
What is the appropriate evaluation and management for a 14-year-old presenting with fever, mild jaundice, and abdominal pain?
What is the recommended thrombolytic treatment for deep vein thrombosis (DVT)?
What are the treatment guidelines for pediatric hemophagocytic lymphohistiocytosis (HLH)?
Which of the following statements are true regarding erythema nodosum?
In a patient already taking atorvastatin 80 mg daily and ezetimibe 10 mg daily who has elevated total cholesterol, low HDL cholesterol, elevated triglycerides, elevated LDL cholesterol, high cholesterol/HDL ratio, high non‑HDL cholesterol, elevated LDL particle number, increased small and medium LDL particles, optimal large HDL particles, abnormal LDL pattern B, low LDL peak size, elevated apolipoprotein B, elevated lipoprotein(a), elevated high‑sensitivity C‑reactive protein, and elevated lipoprotein‑associated phospholipase A2 activity, what is the appropriate treatment strategy?
What target resting heart rate should be aimed for when titrating propranolol in patients with decompensated chronic liver disease, and how should the dose be adjusted?
Are lomotil (diphenoxylate + atropine), fotagel (dioctahedral smectite), and buscopan (hyoscine butylbromide) contraindicated for a breastfeeding mother?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.